Pre-Exposure Prophylaxis for HIV
CE Information
1.0 contact hour (1.0 pharmacology)Completion Time
1 hourAvailable Until
December 31, 2024Posted By
Pacific Lutheran UniversityNavigate
Overview
Specialties
Educational/Research, Nursing Student, and School HealthClinical Topics
AIDS/HIV, Health Literacy, Pharmacology, Primary Care, and TreatmentThis course will cover Pre-Exposure Prophylaxis (PrEP) effectiveness in preventing HIV infection when taken as prescribed. PrEP is recommended for individuals at high risk of HIV, and it involves taking antiretroviral medications regularly to reduce the risk of HIV transmission. Discover the importance of healthcare providers accessing individuals' risk factors to determine if PrEP is appropriate for them. PrEP is highly effective when taken consistently. The two main medications approved for PrEP are Truvada (tenofovir disoproxil fumarate/emtricitabine) and Descovy (tenofovir alafenamide/emtricitabine). Both medications have been shown to significantly reduce the risk of HIV transmission when taken as directed.
Speakers
Clinical Ambulatory Care Pharmacy Specialist
CE Information
This activity offers 1.0 contact hour (1.0 pharmacology) to attendees.
Activity Content
Registration to this activity includes access to the following supporting materials.
- CDC 2022 Opioid Guideline update CCNL 20230506L.pdf (Size: 5.8 MB)
Duration: about 1 hour | Quality: HD
5 questions
Access your certificate
Register For This Activity
Pre-Exposure Prophylaxis for HIV